Ahmed Eltokhi

In vitro effects of eslicarbazepine (S‐licarbazepine) as a potential precision therapy on SCN8A variants causing neuropsychiatric disorders

H. Lerche, U. Hedrich, Y. Sara, 2022, British journal of pharmacology.